Company
United StatesPublic company, NYSE: BMYBristol-Myers Squibb Company (NYSE: BMY), Madison, NJ – FDA Inspections
Inspection records and compliance data for Bristol-Myers Squibb Company in Madison, New Jersey. 17 FDA inspections on record, 4 Form 483s, last inspected June 23, 2026. Publicly traded as NYSE: BMY.
Company Profile
This profile covers Bristol-Myers Squibb Company based in Madison, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 17
- OAI
- 0
- VAI
- 4
- NAI
- 10
- Unclassified
- 3
- Form 483s
- 4
- Warning letters
- 0
First inspected September 3, 2009. Last inspected June 23, 2026.
Most cited issue areas
- Late submission of 15-day report2 inspections
- Absence of Written Procedures1 inspection
- Acceptance criteria for sampling & testing1 inspection
FDA inspections (17)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 23, 2026 | Not classified | Biologics | 1327472 |
| July 18, 2025 | Not classified | Biologics | 1275526 |
| December 6, 2024 | VAI | Human Drugs · Postmarketing Surveillance and Epidemiology: Human Drugs | 1236864 |
| September 6, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1247735 |
| January 31, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1228973 |
| June 16, 2023 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1208871 |
| March 14, 2022 | NAI | Human Drugs · Bioresearch Monitoring | 1165563 |
| June 3, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1124151 |
| July 26, 2019 | NAI | Biologics, Human Drugs · Bioresearch Monitoring | 1100241 |
| June 27, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1059535 |
| March 17, 2017 | NAI | Human Drugs · Bioresearch Monitoring | 1005027 |
| January 25, 2017 | Not classified | Human Drugs · Postmarket Surv. and Epidemiology | 1000482 |
| April 29, 2014 | NAI | Human Drugs · Drug Quality Assurance | 876745 |
| July 30, 2012 | NAI | Human Drugs · Bioresearch Monitoring | 794180 |
| June 17, 2011 | NAI | Human Drugs · Bioresearch Monitoring | 730757 |
| March 19, 2010 | VAI | Human Drugs · Drug Quality Assurance | 653973 |
| September 3, 2009 | VAI | Human Drugs · Bioresearch Monitoring | 611945 |
FDA documents
Form 483s (7)
People (5)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Bristol-Myers Squibb Company
Stock ticker
BMY
Exchange
NYSE
Share price
$62.37
Market cap
$127.5B
Price as of
November 13, 2026
FEI Number
3004991673
Address
5 Giralda Farms, Madison, New Jersey 07940, United States
Country
United States
ID: 3734a119-014f-49c6-b518-fc8b1dea7f92